AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Investor Webinar Recording, page-91

  1. 7,171 Posts.
    lightbulb Created with Sketch. 2727
    In my own mind next positive news catalysts for AC8 will be towards the end of 2019 we are expecting capsules to be submitted for clinical trials which, this should be a nice up move on the announcement as things are finally getting up and running.

    Then results from coming out from then on results from trials.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.